5 Stocks With Big Insider Buying
As of the most recently reported quarter, Dynegy was one of Carl Icahn's holdings. CytRx
Another stock that insiders are warming up too here is CytRx (CYTR) , a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, specializing in oncology. Insiders are buying this stock into some big-time strength since shares are up over 150% so far in 2012.
CytRx has a market cap of $104.95 million and an enterprise value of $70.85 million. This stock trades at a premium valuation, with a price-to-sales of 411.34 and a price-to-book of 7.12. Its estimated growth rate for this year is -74%, and for next year it's pegged at 13.4%. This is a cash-rich company, since the total cash position on its balance sheet is $31.98 million and its total debt is zero.
A beneficial owner just bought 44,824 shares, or about $230,000 worth of stock, at $4.90 per share.